ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 177 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $127,000 | +273.5% | 4,221 | +449.6% | 0.01% | +250.0% |
| Q2 2021 | $34,000 | +13.3% | 768 | +12.1% | 0.00% | 0.0% |
| Q1 2021 | $30,000 | +150.0% | 685 | +23.2% | 0.00% | +100.0% |
| Q3 2020 | $12,000 | +500.0% | 556 | +278.2% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 147 | +54.7% | 0.00% | – |
| Q4 2019 | $2,000 | -97.7% | 95 | -98.7% | 0.00% | -100.0% |
| Q3 2019 | $88,000 | – | 7,521 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |